UTI Mid cap mutual fund evaluation: Needs to plug gap with index

ET Wealth collaborates with Value Research to analyse prime mutual funds. We look at the important thing fundamentals of the fund, its portfolio and efficiency to assist you make an knowledgeable investment determination.

BASIC FACTS
DATE OF LAUNCH


4 JUL 2004

CATEGORY

EQUITY

TYPE

MID CAP

AUM*

Rs.7,348 crore

BENCHMARK

NIFTY MIDCAP 150

TOTAL RETURN INDEX

Image-1
Image-2
Image-3


WHAT IT COSTS
NAV**


GROWTH OPTION

Rs.194.84

IDCW

Rs.92.20

MINIMUM INVESTMENT

Rs.5,000

MINIMUM SIP AMOUNT

Rs.500

EXPENSE RATIO*** (%)

1.78

EXIT LOAD

1% for redemption

inside 364 days

*AS ON 31 OCTOBER 2022
**AS ON 6 DECEMBER 2022
***AS ON 31 OCTOBER 2022


Image-4

Image-5



FUND MANAGER

ANKIT AGARWAL

TENURE: 3 YEARS, 3 MONTHS

Recent portfolio adjustments
New Entrants:
Aarti Pharmalabs, The Ramco Cements.

Complete Exits: NA

Increasing allocation: Bharat Electronics, Dr. Lal Pathlabs, Jubilant FoodWorks, PB Fintech, Sundram Fasteners, Syngene International, United Breweries (Sept), Alkem Labs, Balkrishna Inds, Dr. Lal Pathlabs, Honeywell Automation, PB Fintech, Prestige Estates, Sundram Fasteners, United Breweries (Oct)

Image-6

Should you purchase?

This mid cap fund runs a mix of progress and worth investing fashion with a tilt in the direction of progress. Its desire is for companies with scalable fashions with lengthy progress runway however stays open for firms going by transitory section of weak point or transformational change. The portfolio is closely diversified with modest positions even in prime bets. It is sector agnostic and retains flexibility to keep invested in shares rising into giant caps. The fund’s efficiency has slipped visibly in recent times. While it retains a wholesome risk-return profile, it should plug the gap with index and friends shortly to stay a superb decide.

(Source: Value Research)

.

LEAVE A REPLY

Please enter your comment!
Please enter your name here